Fourth Annual Dengue Endgame Summit

Agenda 2025


Summit Recordings

Brazil’s Worst Dengue Outbreak and Real-World Evidence to Support Disease Control Strategies

Brazil’s Worst Dengue Outbreak and Real-World Evidence to Support Disease Control Strategies

Julio Croda, MD, PhD.

Dengue situation in Bangladesh

Dengue situation in Bangladesh

Tahmina Shirin, PhD.

Dengue fever in the coastal region of Kenya: dominance of DENV-1 and temporal lineage replacement

Dengue fever in the coastal region of Kenya: dominance of DENV-1 and temporal lineage replacement

John Waitumbi, DVM, PhD.

What’s driving the global surge in dengue cases?

What’s driving the global surge in dengue cases?

Henrik Salje, PhD.

After the storm: preparing for dengue’s next chapter

After the storm: preparing for dengue’s next chapter

Kathryn Anderson, MD, PhD, CTropMed.

Dengue Burden - What are we missing

Dengue Burden - What are we missing

Shirin Kalimuddin, MBBS, MPH, PhD.

Estimating Dengue Burden Across Diverse Settings and Data Landscapes

Estimating Dengue Burden Across Diverse Settings and Data Landscapes

Angkana T. Huang, PhD.

Modelling of dengue and dengue vaccination, specific for the location of interest, for accurate estimation of dengue disease burden and optimal vaccination strategies

Modelling of dengue and dengue vaccination, specific for the location of interest, for accurate estimation of dengue disease burden and optimal vaccination strategies

Jing Shen, PhD.

Wolbachia-based control of vector-borne diseases: Promises and Problems

Wolbachia-based control of vector-borne diseases: Promises and Problems

Jason Rasgon, PhD.

Wolbachia-based interventions for arboviral diseases: Will this be a public health success

Wolbachia-based interventions for arboviral diseases: Will this be a public health success

Albert Ko, MD.

Complexities surrounding anti-flavivirus preexisting immunity and dengue disease severity”

Complexities surrounding anti-flavivirus preexisting immunity and dengue disease severity”

Ashley Lauren St. John, PhD.

Dengue virus genetics - not Loki for Endgame?

Dengue virus genetics - not Loki for Endgame?

Eng Eong Ooi, MD, PhD.

Impact of dengue virus genetic diversity on inhibition by Wolbachia

Impact of dengue virus genetic diversity on inhibition by Wolbachia

Chantal Vogels, PhD.

Characterizing dengue: the many faces of severe disease

Characterizing dengue: the many faces of severe disease

Bridget Wills, FRCPCH, DM.

Characterizing burden of dengue fever from the patient’s point of view: Presentation of a novel tool for use in interventional and observational studies

Characterizing burden of dengue fever from the patient’s point of view: Presentation of a novel tool for use in interventional and observational studies

Morgan A. Marks, PhD.

Core Outcome Measurement Set for Clinical Trials in Dengue: An International Delphi Consensus Study ‘DEN-CORE’

Core Outcome Measurement Set for Clinical Trials in Dengue: An International Delphi Consensus Study ‘DEN-CORE’

Daniel Munblit, MD, PhD.

Immunologic lessons learned from dengue human infection models

Immunologic lessons learned from dengue human infection models

Kirsten Lyke, MD.

Reimagining Dengue Therapeutic/Vaccine Clinical Trials

Reimagining Dengue Therapeutic/Vaccine Clinical Trials

Jenny Low Guek Hong, MD.

Dengue Alliance: A South-South Collaboration to Prevent Dengue Deaths Worldwide

Dengue Alliance: A South-South Collaboration to Prevent Dengue Deaths Worldwide

Andre Siqueira, MD.

Achieving equitable access for dengue countermeasures

Achieving equitable access for dengue countermeasures

In-Kyu (Q) Yoon, MD.